Novartis Wants to Deliver CAR-T Therapy to Japanese Patients ASAP: Exec

Toru Hirose, Director and Head of Development Division, Novartis Pharma Novartis is set to bring its investigational chimeric antigen receptor T cell (CAR-T) therapy CTL019 to Japanese patients as soon as possible, Japan development head Toru Hirose said on July...read more